ArticleJournal of contemporary brachytherapy2015

High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer.

Ricardo Cendales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.